AllianceBernstein’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

AllianceBernstein’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-330,850	Closed	-$5.61M	–	3605
2014 Q4	$5.61M	Buy	330,850 +25,150	+8%	+$354K	﹤0.01%	1066
2014 Q3	$3.64M	Buy	305,700 +47,600	+18%	+$325K	﹤0.01%	1267
2014 Q2	$1.46M	Buy	258,100 +17,800	+7%	+$82K	﹤0.01%	2007
2014 Q1	$882K	Sell	240,300 -26,700	-10%	-$102K	﹤0.01%	2225
2013 Q4	$897K	Hold	267,000	–	–	﹤0.01%	2216
2013 Q3	$1.13M	Buy	267,000 +8,383	+3%	+$39.7K	﹤0.01%	2068
2013 Q2	$1.19M	Buy	+258,617	New	+$889K	﹤0.01%	1965

AllianceBernstein's AVNR Position: Q1 2015 in Review

AllianceBernstein sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 330,850 shares — an estimated $5.61M sold.

AllianceBernstein first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $5.61M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

AllianceBernstein reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
AllianceBernstein sold 330,850 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $5.61M.
AllianceBernstein first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
AllianceBernstein's AVANIR PHARMACEUTICALS, INC CL A position peaked at $5.61M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on AllianceBernstein's 13F filing for Q1 2015, filed 13 May 2015.